Abstract
Introduction
Choroid plexus tumors (CPTs) represent one of the most common intraventricular tumors. Although most are benign, they often reach considerable sizes before clinical manifestation, challenging their surgical management. We aim to describe the clinical characteristics and the impact of current management on the survival of patients harboring intraventricular CPT.
Methods
The National Cancer Database (NCDB) was queried to identify biopsy-proven intraventricular CPT patients (2004–2015). Demographic and patterns of care were described, the log-rank method was used to independently analyze survival according to age, WHO grade and extent of resection (EOR). Multivariate analysis was performed to investigate the impact of prognostic factors on overall survival (OS).
Results
A total of 439 CPT patients with known WHO grade were included. WHO grade I tumors were more frequent in adults, while WHO grade III tumors were more common in pediatric population. Most CPTs were benign, with a median tumor size of 3–4 cm. Mean tumor size in pediatric population was greater than in adult population (4.39 cm vs. 2.7 cm; p < 0.01). Frequency was similar between males and females (51.7% vs. 48.3%; p > 0.0.5). Five- and ten-year OS among all patients was 87% and 84%, respectively. EOR was not associated with survival for any WHO grade. On multivariable analysis, only patient age (p = 0.022), WHO grade (p = 0.003) and medical comorbidity scores (p = 0.002) were independently associated with OS after diagnosis.
Conclusion
Patients with CPTs present at different stages of life, with sizable tumor burden and distinct WHO grade prevalence. Considering their favorable survival, efforts to improve tumor control should be meticulously weighed against the long-term risk associated with surgery, radiation, and chemotherapy.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article (and its supplementary information files).
References
Wolff JE, Sajedi M, Brant R, Coppes MJ, Egeler RM (2002) Choroid plexus tumours. Br J Cancer 87(10):1086–1091. https://doi.org/10.1038/sj.bjc.6600609
Bettegowda C, Chen LC, Mehta VA, Jallo GI, Rutka JT (2012) Supratentorial tumors in the pediatric population. In: Schmidek and sweet operative neurosurgical techniques. pp 669–683. https://doi.org/10.1016/b978-1-4160-6839-6.10056-5
Pendleton C, Olivi A, Jallo GI, Quinones-Hinojosa A (2011) Unique challenges faced by pediatric neurosurgeon Harvey Cushing in 1909 at Johns Hopkins: a choroid plexus tumor of the lateral ventricle mimicking a cerebellar lesion. Childs Nerv Syst 27(7):1145–1148. https://doi.org/10.1007/s00381-011-1444-7
Sun MZ, Oh MC, Ivan ME, Kaur G, Safaee M, Kim JM, Phillips JJ, Auguste KI, Parsa AT (2014) Current management of choroid plexus carcinomas. Neurosurg Rev 37(2):179–192. https://doi.org/10.1007/s10143-013-0499-1
Lam S, Lin Y, Cherian J, Qadri U, Harris DA, Melkonian S, Jea A (2013) Choroid plexus tumors in children: a population-based study. Pediatr Neurosurg 49(6):331–338. https://doi.org/10.1159/000367974
Mallick S, Benson R, Melgandi W, Rath GK (2017) Effect of surgery, adjuvant therapy, and other prognostic factors on choroid plexus carcinoma: a systematic review and individual patient data analysis. Int J Radiat Oncol Biol Phys 99(5):1199–1206. https://doi.org/10.1016/j.ijrobp.2017.08.012
Cannon DM, Mohindra P, Gondi V, Kruser TJ, Kozak KR (2015) Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management. J Neurooncol 121(1):151–157. https://doi.org/10.1007/s11060-014-1616-x
Yoshida K, Sato K, Kitai R, Hashimoto N, Kubota T, Kikuta K (2013) Coincident choroid plexus carcinoma and adrenocortical tumor in an infant. Brain Tumor Pathol 30(2):104–108. https://doi.org/10.1007/s10014-012-0112-2
McCall T, Binning M, Blumenthal DT, Jensen RL (2006) Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol 66(1):62–67. https://doi.org/10.1016/j.surneu.2005.09.023
Bettegowda C, Adogwa O, Mehta V, Chaichana KL, Weingart J, Carson BS, Jallo GI, Ahn ES (2012) Treatment of choroid plexus tumors: a 20-year single institutional experience. J Neurosurg Pediatr 10(5):398–405. https://doi.org/10.3171/2012.8.PEDS12132
Bahar M, Hashem H, Tekautz T, Worley S, Tang A, de Blank P, Wolff J (2017) Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience. J Neurooncol 132(3):427–432. https://doi.org/10.1007/s11060-017-2384-1
Wrede B, Liu P, Wolff JE (2007) Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 85(3):345–351. https://doi.org/10.1007/s11060-007-9428-x
Anderson M, Babington P, Taheri R, Diolombi M, Sherman JH (2014) Unique presentation of cerebellopontine angle choroid plexus papillomas: case report and review of the literature. J Neurol Surg Rep 75(1):e27–32. https://doi.org/10.1055/s-0033-1358378
Ozdogan S, Gergin YE, Gergin S, Senol O, Tiryaki M, Tatarli N, Hicdonmez T (2015) Choroid plexus carcinoma in adults: an extremely rare case. Pan Afr Med J 20:302. https://doi.org/10.11604/pamj.2015.20.302.5854
Lozier AP, Arbaje YM, Scheithauer BW (2009) Supratentorial, extraventricular choroid plexus carcinoma in an adult: case report. Neurosurgery 65(4):E816–817. https://doi.org/10.1227/01.NEU.0000348291.48810.C2
Wilhelm M, Hirsch W, Merkenschlager A, Stepan H, Geyer C, Kiess W (2012) A rare case of congenital choroid plexus carcinoma. Pediatr Hematol Oncol 29(7):643–646. https://doi.org/10.3109/08880018.2012.710298
Lin H, Leng X, Qin CH, Du YX, Wang WS, Qiu SJ (2019) Choroid plexus tumours on MRI: similarities and distinctions in different grades. Cancer Imaging 19(1):17. https://doi.org/10.1186/s40644-019-0200-1
Bishop AJ, McDonald MW, Chang AL, Esiashvili N (2012) Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data. Int J Radiat Oncol Biol Phys 82(1):341–347. https://doi.org/10.1016/j.ijrobp.2010.08.020
Dhillon RS, Wang YY, McKelvie PA, O'Brien B (2013) Progression of choroid plexus papilloma. J Clin Neurosci 20(12):1775–1778. https://doi.org/10.1016/j.jocn.2012.11.027
Niikawa S, Ito T, Murakawa T, Hirayama H, Ando T, Sakai N, Yamada H (1993) Recurrence of choroid plexus papilloma with malignant transformation–case report and lectin histochemistry study. Neurol Med Chir (Tokyo) 33(1):32–35. https://doi.org/10.2176/nmc.33.32
Zhou WJ, Wang X, Peng JY, Ma SC, Zhang DN, Guan XD, Diao JF, Niu JX, Li CD, Jia W (2018) Clinical features and prognostic risk factors of choroid plexus tumors in children. Chin Med J (Engl) 131(24):2938–2946. https://doi.org/10.4103/0366-6999.247195
Wrede B, Liu P, Ater J, Wolff JE (2005) Second surgery and the prognosis of choroid plexus carcinoma–results of a meta-analysis of individual cases. Anticancer Res 25(6C):4429–4433
Pencalet P, Sainte-Rose C, Lellouch-Tubiana A, Kalifa C, Brunelle F, Sgouros S, Meyer P, Cinalli G, Zerah M, Pierre-Kahn A, Renier D (1998) Papillomas and carcinomas of the choroid plexus in children. J Neurosurg 88(3):521–528. https://doi.org/10.3171/jns.1998.88.3.0521
Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fevre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobagyi T, Klekner A, Laszlo B, Pocza T, Hauser P, Schuller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, Lopez-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD (2016) Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol 17(4):484–495. https://doi.org/10.1016/S1470-2045(15)00581-1
Hargrave D (2016) Extent of resection in medulloblastoma: time to reconsider? Lancet Oncol 17(4):409–410. https://doi.org/10.1016/S1470-2045(16)00143-1
Ogiwara H, Dipatri AJ Jr, Alden TD, Bowman RM, Tomita T (2012) Choroid plexus tumors in pediatric patients. Br J Neurosurg 26(1):32–37. https://doi.org/10.3109/02688697.2011.601820
St Clair SK, Humphreys RP, Pillay PK, Hoffman HJ, Blaser SI, Becker LE (1991) Current management of choroid plexus carcinoma in children. Pediatr Neurosurg 17(5):225–233. https://doi.org/10.1159/000120602
Sun MZ, Ivan ME, Clark AJ, Oh MC, Delance AR, Oh T, Safaee M, Kaur G, Bloch O, Molinaro A, Gupta N, Parsa AT (2014) Gross total resection improves overall survival in children with choroid plexus carcinoma. J Neurooncol 116(1):179–185. https://doi.org/10.1007/s11060-013-1281-5
Crea A, Bianco A, Cossandi C, Forgnone S, Fornaro R, Crobeddu E, Marino D, Piras G, Scalia G, Saglietti C, Boldorini R, Galzio R, Panzarasa G (2020) Choroid plexus carcinoma in adults: literature review and first report of a location into the third ventricle. World Neurosurg 133:302–307. https://doi.org/10.1016/j.wneu.2019.10.051
Zaky W, Dhall G, Khatua S, Brown RJ, Ginn KF, Gardner SL, Yildiz VO, Yankelevich M, Finlay JL (2015) Choroid plexus carcinoma in children: the Head Start experience. Pediatr Blood Cancer 62(5):784–789. https://doi.org/10.1002/pbc.25436
Zaky W, Finlay JL (2018) Pediatric choroid plexus carcinoma: biologically and clinically in need of new perspectives. Pediatr Blood Cancer 65(7):e27031. https://doi.org/10.1002/pbc.27031
Safaee M, Oh MC, Sughrue ME, Delance AR, Bloch O, Sun M, Kaur G, Molinaro AM, Parsa AT (2013) The relative patient benefit of gross total resection in adult choroid plexus papillomas. J Clin Neurosci 20(6):808–812. https://doi.org/10.1016/j.jocn.2012.08.003
Levy ML, Goldfarb A, Hyder DJ, Gonzales-Gomez I, Nelson M, Gilles FH, McComb JG (2001) Choroid plexus tumors in children: significance of stromal invasion. Neurosurgery 48(2):303–309. https://doi.org/10.1097/00006123-200102000-00010
Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, Quinones-Hinojosa A, Chaichana KL (2019) Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-analysis. World Neurosurg 127:31–37. https://doi.org/10.1016/j.wneu.2019.03.250
Adams H, Adams HH, Jackson C, Rincon-Torroella J, Jallo GI, Quinones-Hinojosa A (2016) Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis. Childs Nerv Syst 32(3):493–503. https://doi.org/10.1007/s00381-015-3006-x
Mampre D, Ehresman J, Pinilla-Monsalve G, Osorio MAG, Olivi A, Quinones-Hinojosa A, Chaichana KL (2018) Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. Br J Neurosurg 32(5):528–535. https://doi.org/10.1080/02688697.2018.1498450
Almeida JP, Chaichana KL, Rincon-Torroella J, Quinones-Hinojosa A (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15(2):517. https://doi.org/10.1007/s11910-014-0517-x
Chaichana KL, Jusue-Torres I, Lemos AM, Gokaslan A, Cabrera-Aldana EE, Ashary A, Olivi A, Quinones-Hinojosa A (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625–634. https://doi.org/10.1007/s11060-014-1597-9
Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I, Wijesekera O, Olivi A, Rahman M, Quinones-Hinojosa A (2014) When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg 82(1–2):e257–265. https://doi.org/10.1016/j.wneu.2014.01.019
Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A (2014) Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 16(1):113–122. https://doi.org/10.1093/neuonc/not137
McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinones-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63(4):700–707. https://doi.org/10.1227/01.NEU.0000325729.41085.73
McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa AR (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1):156–162. https://doi.org/10.3171/2008.4.17536
Funding
This publication was made possible through the support of the Eveleigh Family Career Development Award for Cancer Research at Mayo Clinic in Florida.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflict of interests to report or financial disclosures related to this manuscript.
Ethical approval
There is compliance with ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11060_2020_3603_MOESM1_ESM.pdf
Supplementary file1 (PDF 163 kb). Fig. 1a, b WHO grade distribution according to age (A) and sex (B).WHO: World Health Organization.
11060_2020_3603_MOESM2_ESM.pptx
Supplementary file2 (PPTX 1874 kb). Fig. 2 Kaplan-Meier curve of overall survival based on extent ofresection in WHO grade 2 (A) and WHO grade 3 (B) patients. WHO: World Health Organization.
11060_2020_3603_MOESM3_ESM.docx
Supplementary file3 (DOCX 31 kb). Tables 1, 2 Extend of resection according to age, WHO grade classification and tumor size; Use of radiation therapy or chemotherapy according to WHO grade classification.
Rights and permissions
About this article
Cite this article
Ruiz-Garcia, H., Huayllani, M.T., Incontri, D. et al. Intraventricular choroid plexus tumors: clinical characteristics and impact of current management on survival. J Neurooncol 149, 283–292 (2020). https://doi.org/10.1007/s11060-020-03603-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-020-03603-8